Currently, researchers are more likely attribute to the beneficial effect of DPP-4 inhibitors on diabetes to GLP-1 (31, 32), but studies showed that other substrate such as SDF-1α has a function on protection β-cell survival as well. This evidence concerns the gene CXCL12 and diabetes mellitus.